학술논문
Maintenance olaparib rechallenge in patients with platinum-sensitive relapsed ovarian cancer previously treated with a PARP inhibitor (OReO/ENGOT-ov38): a phase IIIb trial
Document Type
Article
Author
Pujade-Lauraine, E.; Selle, F.; Scambia, G.; Asselain, B.; Marmé, F.; Lindemann, K.; Colombo, N.; Mądry, R.; Glasspool, R.; Vergote, I.; Korach, J.; Lheureux, S.; Dubot, C.; Oaknin, A.; Zamagni, C.; Heitz, F.; Gladieff, L.; Rubio-Pérez, M.J.; Scollo, P.; Blakeley, C.; Shaw, B.; Ray-Coquard, I.; Redondo, A.
Source
In Annals of Oncology December 2023 34(12):1152-1164
Subject
Language
ISSN
0923-7534